A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration
Clinical trial NCT00950638 · COMPLETED
Trial details
- NCT number
- NCT00950638
- Sponsor
- Ophthotech Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-16
- Primary completion
- 2011-03-24
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.